Annual EBIT:
-$235.52M+$76.78M(+24.59%)Summary
- As of today, ALNY annual earnings before interest & taxes is -$235.52 million, with the most recent change of +$76.78 million (+24.59%) on December 31, 2024.
- During the last 3 years, ALNY annual EBIT has risen by +$473.61 million (+66.79%).
- ALNY annual EBIT is now -5478.33% below its all-time high of -$4.22 million, reached on December 31, 2002.
Performance
ALNY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$4.89M+$7.84M(+265.69%)Summary
- As of today, ALNY quarterly earnings before interest & taxes is $4.89 million, with the most recent change of +$7.84 million (+265.69%) on June 30, 2025.
- Over the past year, ALNY quarterly EBIT has dropped by -$17.20 million (-77.87%).
- ALNY quarterly EBIT is now -97.31% below its all-time high of $181.63 million, reached on September 30, 2023.
Performance
ALNY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$227.34M-$17.20M(-8.19%)Summary
- As of today, ALNY TTM earnings before interest & taxes is -$227.34 million, with the most recent change of -$17.20 million (-8.19%) on June 30, 2025.
- Over the past year, ALNY TTM EBIT has dropped by -$296.38 million (-429.27%).
- ALNY TTM EBIT is now -429.27% below its all-time high of $69.04 million, reached on June 30, 2024.
Performance
ALNY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ALNY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +24.6% | -77.9% | -429.3% |
| 3Y3 Years | +66.8% | +102.1% | +72.2% |
| 5Y5 Years | +73.4% | +103.2% | +72.7% |
ALNY EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +75.8% | -97.3% | +101.3% | -429.3% | +77.7% |
| 5Y | 5-Year | at high | +75.8% | -97.3% | +101.3% | -429.3% | +77.7% |
| All-Time | All-Time | -5478.3% | +75.8% | -97.3% | +101.3% | -429.3% | +77.7% |
ALNY EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $4.89M(+265.7%) | -$227.34M(-8.2%) |
| Mar 2025 | - | -$2.95M(+98.1%) | -$210.13M(+10.8%) |
| Dec 2024 | -$235.52M(+24.6%) | -$154.99M(-108.6%) | -$235.52M(-26.0%) |
| Sep 2024 | - | -$74.29M(-436.3%) | -$186.88M(-370.7%) |
| Jun 2024 | - | $22.09M(+178.0%) | $69.04M(+135.0%) |
| Mar 2024 | - | -$28.33M(+73.4%) | -$197.22M(+36.8%) |
| Dec 2023 | -$312.30M(+67.8%) | -$106.35M(-158.6%) | -$312.30M(+18.5%) |
| Sep 2023 | - | $181.63M(+174.4%) | -$383.06M(+58.8%) |
| Jun 2023 | - | -$244.17M(-70.3%) | -$929.55M(-1.3%) |
| Mar 2023 | - | -$143.41M(+19.0%) | -$917.44M(+5.5%) |
| Dec 2022 | -$971.02M(-36.9%) | -$177.11M(+51.5%) | -$971.02M(+4.6%) |
| Sep 2022 | - | -$364.86M(-57.2%) | -$1.02B(-24.6%) |
| Jun 2022 | - | -$232.06M(-17.8%) | -$816.51M(-10.4%) |
| Mar 2022 | - | -$196.99M(+11.9%) | -$739.36M(-4.3%) |
| Dec 2021 | -$709.12M(+8.0%) | -$223.49M(-36.3%) | -$709.12M(-1.2%) |
| Sep 2021 | - | -$163.96M(-5.8%) | -$700.72M(+7.9%) |
| Jun 2021 | - | -$154.91M(+7.1%) | -$760.48M(-0.6%) |
| Mar 2021 | - | -$166.76M(+22.5%) | -$756.22M(+1.9%) |
| Dec 2020 | -$771.10M(+12.9%) | -$215.08M(+3.9%) | -$771.10M(+7.4%) |
| Sep 2020 | - | -$223.72M(-48.5%) | -$832.61M(-1.8%) |
| Jun 2020 | - | -$150.66M(+17.1%) | -$817.81M(+7.7%) |
| Mar 2020 | - | -$181.65M(+34.3%) | -$885.68M(+0.8%) |
| Dec 2019 | -$885.25M(-16.4%) | -$276.58M(-32.4%) | -$892.82M(-14.1%) |
| Sep 2019 | - | -$208.93M(+4.4%) | -$782.60M(+5.5%) |
| Jun 2019 | - | -$218.52M(-15.7%) | -$828.22M(-3.3%) |
| Mar 2019 | - | -$188.79M(-13.5%) | -$802.06M(-5.4%) |
| Dec 2018 | -$760.67M(-52.1%) | -$166.36M(+34.6%) | -$760.67M(-2.6%) |
| Sep 2018 | - | -$254.56M(-32.3%) | -$741.62M(-21.0%) |
| Jun 2018 | - | -$192.35M(-30.5%) | -$612.86M(-13.3%) |
| Mar 2018 | - | -$147.41M(-0.1%) | -$540.98M(-8.2%) |
| Dec 2017 | -$500.09M(-17.8%) | -$147.30M(-17.1%) | -$500.09M(-6.8%) |
| Sep 2017 | - | -$125.80M(-4.4%) | -$468.22M(-4.3%) |
| Jun 2017 | - | -$120.47M(-13.1%) | -$449.09M(-6.7%) |
| Mar 2017 | - | -$106.51M(+7.7%) | -$421.07M(+0.8%) |
| Dec 2016 | -$424.59M(-43.4%) | -$115.43M(-8.2%) | -$424.59M(-5.7%) |
| Sep 2016 | - | -$106.68M(-15.4%) | -$401.67M(-7.6%) |
| Jun 2016 | - | -$92.45M(+16.0%) | -$373.32M(-5.5%) |
| Mar 2016 | - | -$110.03M(-18.9%) | -$353.81M(-19.5%) |
| Dec 2015 | -$296.01M(-60.7%) | -$92.51M(-18.1%) | -$296.01M(-18.8%) |
| Sep 2015 | - | -$78.33M(-7.4%) | -$249.21M(-15.3%) |
| Jun 2015 | - | -$72.94M(-39.7%) | -$216.08M(-12.5%) |
| Mar 2015 | - | -$52.22M(-14.2%) | -$192.03M(-4.2%) |
| Dec 2014 | -$184.21M | -$45.71M(-1.1%) | -$184.21M(-9.6%) |
| Sep 2014 | - | -$45.20M(+7.6%) | -$168.09M(-8.4%) |
| Jun 2014 | - | -$48.90M(-10.1%) | -$155.13M(-21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$44.41M(-50.1%) | -$127.55M(-37.2%) |
| Dec 2013 | -$92.94M(-46.2%) | -$29.59M(+8.2%) | -$92.94M(-7.2%) |
| Sep 2013 | - | -$32.23M(-51.2%) | -$86.70M(-19.4%) |
| Jun 2013 | - | -$21.31M(-117.4%) | -$72.62M(-14.6%) |
| Mar 2013 | - | -$9.80M(+58.0%) | -$63.37M(+0.3%) |
| Dec 2012 | -$63.57M(-16.0%) | -$23.35M(-28.7%) | -$63.57M(-18.2%) |
| Sep 2012 | - | -$18.15M(-50.4%) | -$53.80M(-11.9%) |
| Jun 2012 | - | -$12.07M(-20.7%) | -$48.09M(+2.1%) |
| Mar 2012 | - | -$10.00M(+26.4%) | -$49.14M(+10.4%) |
| Dec 2011 | -$54.82M(-25.3%) | -$13.59M(-9.2%) | -$54.82M(-2.8%) |
| Sep 2011 | - | -$12.44M(+5.2%) | -$53.31M(-7.5%) |
| Jun 2011 | - | -$13.12M(+16.3%) | -$49.60M(-3.1%) |
| Mar 2011 | - | -$15.68M(-29.8%) | -$48.11M(-10.0%) |
| Dec 2010 | -$43.74M(+7.0%) | -$12.08M(-38.4%) | -$43.74M(-13.2%) |
| Sep 2010 | - | -$8.73M(+24.9%) | -$38.63M(+2.3%) |
| Jun 2010 | - | -$11.63M(-2.8%) | -$39.55M(+21.4%) |
| Mar 2010 | - | -$11.31M(-62.3%) | -$50.33M(-7.1%) |
| Dec 2009 | -$47.01M(-90.6%) | -$6.97M(+27.8%) | -$47.01M(-5.2%) |
| Sep 2009 | - | -$9.65M(+56.9%) | -$44.68M(-16.8%) |
| Jun 2009 | - | -$22.41M(-180.9%) | -$38.26M(-33.4%) |
| Mar 2009 | - | -$7.98M(-72.1%) | -$28.68M(-16.3%) |
| Dec 2008 | -$24.66M(+68.8%) | -$4.64M(-43.4%) | -$24.66M(-177.8%) |
| Sep 2008 | - | -$3.23M(+74.8%) | -$8.88M(+84.4%) |
| Jun 2008 | - | -$12.83M(-224.3%) | -$56.98M(+3.6%) |
| Mar 2008 | - | -$3.96M(-135.5%) | -$59.10M(+25.3%) |
| Dec 2007 | -$79.14M(-100.3%) | $11.15M(+121.7%) | -$79.14M(+21.1%) |
| Sep 2007 | - | -$51.34M(-243.3%) | -$100.28M(-74.3%) |
| Jun 2007 | - | -$14.95M(+37.7%) | -$57.54M(-7.2%) |
| Mar 2007 | - | -$23.99M(-140.2%) | -$53.70M(-35.9%) |
| Dec 2006 | -$39.50M(+9.1%) | -$9.99M(-16.1%) | -$39.50M(+11.1%) |
| Sep 2006 | - | -$8.60M(+22.5%) | -$44.43M(+4.4%) |
| Jun 2006 | - | -$11.11M(-13.4%) | -$46.49M(+0.2%) |
| Mar 2006 | - | -$9.80M(+34.3%) | -$46.59M(-7.2%) |
| Dec 2005 | -$43.47M(-34.7%) | -$14.92M(-39.8%) | -$43.47M(-27.5%) |
| Sep 2005 | - | -$10.67M(+4.8%) | -$34.09M(-14.2%) |
| Jun 2005 | - | -$11.20M(-67.7%) | -$29.84M(-16.5%) |
| Mar 2005 | - | -$6.68M(-20.8%) | -$25.61M(+20.6%) |
| Dec 2004 | -$32.26M(-57.8%) | -$5.53M(+13.9%) | -$32.26M(+31.8%) |
| Sep 2004 | - | -$6.43M(+7.9%) | -$47.31M(-15.8%) |
| Jun 2004 | - | -$6.97M(+47.7%) | -$40.84M(-14.6%) |
| Mar 2004 | - | -$13.33M(+35.2%) | -$35.65M(-51.2%) |
| Dec 2003 | -$20.45M(-384.3%) | -$20.58M(>-9900.0%) | -$23.59M(-684.6%) |
| Sep 2003 | - | $44.00K(+102.5%) | -$3.01M(+1.4%) |
| Jun 2003 | - | -$1.78M(-40.9%) | -$3.05M(-140.9%) |
| Mar 2003 | - | -$1.27M | -$1.27M |
| Dec 2002 | -$4.22M | - | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of ALNY is -$235.52M
What is the all-time high annual EBIT for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$4.22M
What is Alnylam Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, ALNY annual earnings before interest & taxes has changed by +$76.78M (+24.59%)
What is Alnylam Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ALNY is $4.89M
What is the all-time high quarterly EBIT for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $181.63M
What is Alnylam Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, ALNY quarterly earnings before interest & taxes has changed by -$17.20M (-77.87%)
What is Alnylam Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ALNY is -$227.34M
What is the all-time high TTM EBIT for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $69.04M
What is Alnylam Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, ALNY TTM earnings before interest & taxes has changed by -$296.38M (-429.27%)